Skip to content
Advertisements

Bio CDMO space welcomes this new but established player

video2

Celltrion (KRX:068270) launched its Bio CDMO (Contract Development and Manufacturing) business, on a quest to pursue open innovation for development of new drugs.

Company’s focus activities under this BU include but are not limited to:

  • Outsourcing of biologic cell line development and production process, etc.,
  • Manufacture outsourcing of non-clinical material, clinical material, and commercialised material.

Taking in-development products to pool of commercialisation is claimed to  be major objective of this CDMO venture.

Celltrion plans to support end client through accumulated  expertise in bio-pharma space, and may explore strategic alliance or in-licensing deal with its end clientele.

 

Company details

Website

http://www.celltrion.com

Headquarters

Incheon city

Year founded

2002

Company type

Public Company

Company size

1,001-5,000 employees

Specialties

Biologics, Biosimilar, Biotechnology, and CMO

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: